UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A novel event-free survival endpoint in locally advanced pancreatic cancer

Therapeutic Advances in Medical Oncology, 2021-11, Vol.13, p.17588359211059586-17588359211059586

2021

Volltextzugriff (PDF)

A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation

Blood, 2009-03, Vol.113 (12), p.2646-2654

2009

Volltextzugriff (PDF)

Induction of apoptosis in human lung cancer cells by curcumin

Cancer letters, 2004-05, Vol.208 (2), p.163-170

2004

Volltextzugriff (PDF)

Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia?

Journal of translational medicine, 2008-08, Vol.6 (1), p.45-45, Article 45

2008

Volltextzugriff (PDF)

Lasers, stem cells, and COPD

Journal of translational medicine, 2010-02, Vol.8 (1), p.16-16, Article 16

2010

Volltextzugriff (PDF)

Multiple myeloma bone marrow niche

Current pharmaceutical biotechnology, 2009-04, Vol.10 (3), p.345-346

2009

Volltextzugriff (PDF)

Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma − Heading towards a promising change in treatment paradigm

Cancer treatment reviews, 2024-06, Vol.127, p.102750, Article 102750

2024

Volltextzugriff (PDF)

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

Journal of translational medicine, 2011-03, Vol.9 (1), p.34-34, Article 34

2011

Volltextzugriff (PDF)

Human embryonic stem cells hemangioblast express HLA-antigens

Journal of translational medicine, 2009-04, Vol.7 (27), p.27-27, Article 27

2009

Volltextzugriff (PDF)

Expression of the epigenetic factor BORIS (CTCFL) in the human genome

Journal of translational medicine, 2011-12, Vol.9 (1), p.213-213, Article 213

2011

Volltextzugriff (PDF)

Inhibition of intracranial glioma growth by endometrial regenerative cells

Cell cycle (Georgetown, Tex.), 2009-02, Vol.8 (4), p.606-610

2009

Volltextzugriff (PDF)

Artificial hematopoietic stem cell niche: bioscaffolds to microfluidics to mathematical simulations

Current topics in medicinal chemistry, 2011-07, Vol.11 (13), p.1599-1605

2011

Volltextzugriff (PDF)

Abstract 983: Design and methodology of LAPIS, an ongoing, phase III trial of neoadjuvant pamrevlumab (pam) with chemotherapy (CT) in patients (pts) with unresectable, locally advanced pancreatic cancer (LAPC)

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.983-983

2023

Volltextzugriff (PDF)

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

Blood, 2009-02, Vol.113 (7), p.1581-1588

2009

Volltextzugriff (PDF)

Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer

ESMO open, 2020-08, Vol.5 (4), p.e000668, Article e000668

2020

Volltextzugriff (PDF)

In utero detection of T7 phage after systemic administration to pregnant mice

BioTechniques, 2004-07, Vol.37 (1), p.81-83

2004

Volltextzugriff (PDF)

Prognostic utility of inflammation biomarkers in a PDAC trial involving the human anti-CTGF antibody pamrevlumab

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.752-752

2020

Volltextzugriff (PDF)

Prospects of embryonic stem cells in treatment of hematopoietic disorders

Current pharmaceutical biotechnology, 2007-10, Vol.8 (5), p.305-317

2007

Volltextzugriff (PDF)

Effect of anti-CTGF human recombinant monoclonal antibody pamrevlumab on resectability and resection rate when combined with gemcitabine/nab-paclitaxel in phase 1/2 clinical study for the treatment of locally advanced pancreatic cancer patients

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.4016-4016

2018

Volltextzugriff (PDF)

Molecular integrity and global gene expression of breast and lung cancer stem cells under long-term storage and recovery

Cell and tissue banking, 2013-06, Vol.14 (2), p.175-186

2013

Volltextzugriff (PDF)

Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy

Journal of neuromuscular diseases, 2023-01, Vol.10 (4), p.685-699

2023

Volltextzugriff (PDF)

Murine Sca-1+/Lin− cells and human KG1a cells exhibit multiple pseudopod morphologies during migration

Experimental hematology, 2002-05, Vol.30 (5), p.460-463

2002

Volltextzugriff (PDF)

Abstract 5367: Long-term survival in a phase II atudy of belagenpumatucel-L (TGF-β antisense modified tumor cell vaccine) in non-small cell lung cancer (NSCLC)

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5367-5367

2012

Volltextzugriff (PDF)

Randomized, open-label trial of gemcitabine/nab-paclitaxel (G/NP) ± pamrevlumab (P) as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer (LAPC)

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.365-365

2017

Volltextzugriff (PDF)

Abstract 5364: Correlation of immune responses and overall survival in a phase II study of belagenpumatucel-L, an allogeneic tumor cell vaccine, in non-small cell lung cancer (NSCLC)

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5364-5364

2012

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(80)
Buchkapitel
(1)

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(48)
Humans
(28)
Animals
(25)
Mice
(18)
Female
(17)
Biological And Medical Sciences
(13)
Transplantation
(12)
Hematology
(11)
Male
(10)
Mice, Inbred C57bl
(10)
Biochemistry & Molecular Biology
(9)
Medical Sciences
(9)
Medicine, Research & Experimental
(9)
Oncology
(9)
Research & Experimental Medicine
(9)
Immunology
(8)
Cell Biology
(7)
Mice, Inbred Balb C
(7)
Biotechnology & Applied Microbiology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A novel event-free survival endpoint in locally advanced pancreatic cancer

A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation

Induction of apoptosis in human lung cancer cells by curcumin

Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia?

Lasers, stem cells, and COPD

Multiple myeloma bone marrow niche

Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma − Heading towards a promising change in treatment paradigm

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

Human embryonic stem cells hemangioblast express HLA-antigens

Expression of the epigenetic factor BORIS (CTCFL) in the human genome

Inhibition of intracranial glioma growth by endometrial regenerative cells

Artificial hematopoietic stem cell niche: bioscaffolds to microfluidics to mathematical simulations

Abstract 983: Design and methodology of LAPIS, an ongoing, phase III trial of neoadjuvant pamrevlumab (pam) with chemotherapy (CT) in patients (pts) with unresectable, locally advanced pancreatic cancer (LAPC)

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer

In utero detection of T7 phage after systemic administration to pregnant mice

Prognostic utility of inflammation biomarkers in a PDAC trial involving the human anti-CTGF antibody pamrevlumab

Prospects of embryonic stem cells in treatment of hematopoietic disorders

Effect of anti-CTGF human recombinant monoclonal antibody pamrevlumab on resectability and resection rate when combined with gemcitabine/nab-paclitaxel in phase 1/2 clinical study for the treatment of locally advanced pancreatic cancer patients

Molecular integrity and global gene expression of breast and lung cancer stem cells under long-term storage and recovery

Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy

Murine Sca-1+/Lin− cells and human KG1a cells exhibit multiple pseudopod morphologies during migration

Abstract 5367: Long-term survival in a phase II atudy of belagenpumatucel-L (TGF-β antisense modified tumor cell vaccine) in non-small cell lung cancer (NSCLC)

Randomized, open-label trial of gemcitabine/nab-paclitaxel (G/NP) ± pamrevlumab (P) as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer (LAPC)

Abstract 5364: Correlation of immune responses and overall survival in a phase II study of belagenpumatucel-L, an allogeneic tumor cell vaccine, in non-small cell lung cancer (NSCLC)

Suchergebnisse filtern